$ACAD
ACADIA PHARMACEUTICALS INC Stock $acad

2011 Q4 Form 10-Q Financial Statement

Concept	2011 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$31.00M
YoY Change	-16.41%
Cash & Equivalents	$6.889M
Short-Term Investments	$24.20M
Other Short-Term Assets	$900.0K
YoY Change	12.5%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$31.95M
YoY Change	-15.59%
LONG-TERM ASSETS
Property, Plant & Equipment	$151.0K
YoY Change	-62.25%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$14.00K
YoY Change	-86.0%
Total Long-Term Assets	$165.0K
YoY Change	-69.72%
TOTAL ASSETS
Total Short-Term Assets	$31.95M
Total Long-Term Assets	$165.0K
Total Assets	$32.11M
YoY Change	-16.36%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.960M
YoY Change	-0.61%
Accrued Expenses	$3.504M
YoY Change	8.85%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00
YoY Change
Long-Term Debt Due	$32.00K
YoY Change	-68.0%
Total Short-Term Liabilities	$6.165M
YoY Change	2.75%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00
YoY Change
Other Long-Term Liabilities	$2.600M
YoY Change	1996.77%
Total Long-Term Liabilities	$2.600M
YoY Change	1996.77%
TOTAL LIABILITIES
Total Short-Term Liabilities	$6.165M
Total Long-Term Liabilities	$2.600M
Total Liabilities	$8.752M
YoY Change	0.53%
SHAREHOLDERS EQUITY
Retained Earnings	-$346.9M
YoY Change	7.02%
Common Stock	$5.000K
YoY Change	25.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$23.36M
YoY Change
Total Liabilities & Shareholders Equity	$32.11M
YoY Change	-16.36%

Concept	2011 Q4
OPERATING ACTIVITIES
Net Income	-$5.300M
YoY Change	-118.21%
Depreciation, Depletion And Amortization	$30.00K
YoY Change	-85.0%
Cash From Operating Activities	-$5.340M
YoY Change	-215.84%
INVESTING ACTIVITIES
Capital Expenditures	$0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$3.810M
YoY Change	-149.1%
Cash From Investing Activities	$3.810M
YoY Change	-149.1%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	90.00K
YoY Change	-75.0%
NET CHANGE
Cash From Operating Activities	-5.340M
Cash From Investing Activities	3.810M
Cash From Financing Activities	90.00K
Net Change In Cash	-1.440M
YoY Change	-48.39%
FREE CASH FLOW
Cash From Operating Activities	-$5.340M
Capital Expenditures	$0.00
Free Cash Flow	-$5.340M
YoY Change	-215.84%

Frame	Concept Type	Concept / XBRL Key	Value
CY2011Q4	us-gaap	Liabilities Current LiabilitiesCurrent	6165000
CY2011Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	32000
CY2011Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	14000
CY2011Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	901000
CY2011Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	151000
CY2011Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	9000
CY2011Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	370219000
CY2011Q4	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	24159000
CY2011Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2011Q4	us-gaap	Common Stock Value CommonStockValue	5000
CY2011Q4	us-gaap	Liabilities Liabilities	8752000
CY2011Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	32114000
CY2011Q4	us-gaap	Preferred Stock Value PreferredStockValue
CY2011Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-346871000
CY2011Q4	us-gaap	Stockholders Equity StockholdersEquity	23362000